| 1 | What guidance exists to support patient partner compensation practices? A scoping review of available policies and guidelines | 3.1 | 16 | Citations (PDF) |
| 2 | Effectiveness of dexmedetomidine during surgery under general anaesthesia on patient-centred outcomes: a systematic review and Bayesian meta-analysis protocol | 2.0 | 4 | Citations (PDF) |
| 3 | A preclinical systematic review and meta-analysis assessing the effect of biological sex in lipopolysaccharide-induced acute lung injury | 3.5 | 11 | Citations (PDF) |
| 4 | Effectiveness of dexmedetomidine on patient-centred outcomes in surgical patients: a systematic review and Bayesian meta-analysis | 3.6 | 17 | Citations (PDF) |
| 5 | Synthesizing regulatory guidance for demonstrating preclinical efficacy and translating promising cell therapies to early phase clinical trials: a scoping review | 7.5 | 7 | Citations (PDF) |
| 6 | Identifying barriers and enablers to rigorous conduct and reporting of preclinical laboratory studies | 5.2 | 7 | Citations (PDF) |
| 7 | Intraoperative pharmacologic opioid minimisation strategies and patient-centred outcomes after surgery: a scoping review protocol | 2.0 | 9 | Citations (PDF) |
| 8 | Engaging patients in anesthesiology research: a rewarding frontier | 1.6 | 9 | Citations (PDF) |
| 9 | An International Society for Cell and Gene Therapy Mesenchymal Stromal Cells (MSC) Committee perspectives on International Standards Organization/Technical Committee 276 Biobanking Standards for bone marrow-MSCs and umbilical cord tissue–derived MSCs for research purposes | 0.6 | 21 | Citations (PDF) |
| 10 | Biodistribution of mesenchymal stromal cell-derived extracellular vesicles administered during acute lung injury | 6.9 | 25 | Citations (PDF) |
| 11 | Association of preoperative anaesthesia consultation prior to elective noncardiac surgery with patient and health system outcomes: a population-based study | 3.6 | 3 | Citations (PDF) |
| 12 | A call to implement preclinical study registration in animal ethics review | 5.2 | 7 | Citations (PDF) |
| 13 | Development and evaluation of an evidence-based, theory-grounded online Clinical Frailty Scale tutorial | 1.8 | 21 | Citations (PDF) |
| 14 | Definition and Characteristics of Mesenchymal Stromal Cells in Preclinical and Clinical Studies: A Scoping Review | 3.6 | 46 | Citations (PDF) |
| 15 | Association between frailty and patient outcomes after cancer surgery: a population-based cohort study | 3.6 | 39 | Citations (PDF) |
| 16 | Patient prioritization of routine and patient-reported postoperative outcome measures: a prospective, nested cross-sectional study | 1.6 | 35 | Citations (PDF) |
| 17 | Mesenchymal stem/stromal cell–based therapies for COVID-19: First iteration of a living systematic review and meta-analysis | 0.6 | 20 | Citations (PDF) |
| 18 | Airway recommendations for perioperative patients during the COVID-19 pandemic: a scoping review | 1.6 | 5 | Citations (PDF) |
| 19 | A systematic approach to enhance transparency in mesenchymal stromal cell research | 0.6 | 3 | Citations (PDF) |
| 20 | Understanding potential barriers and enablers to a perioperative early phase cell therapy trial | 0.6 | 2 | Citations (PDF) |
| 21 | Assessing the impact of predatory journals on policy and guidance documents: a cross-sectional study protocol | 2.0 | 9 | Citations (PDF) |
| 22 | Building a Platform for Meaningful Patient Partnership to Accelerate “Bench-to-Bedside” Translation of Promising New Therapies | 0.6 | 1 | Citations (PDF) |
| 23 | Home-based prehabilitation with exercise to improve postoperative recovery for older adults with frailty having cancer surgery: the PREHAB randomised clinical trial | 3.6 | 100 | Citations (PDF) |
| 24 | Updated Living Systematic Review and Meta-analysis of Controlled Trials of Mesenchymal Stromal Cells to Treat COVID-19: A Framework for Accelerated Synthesis of Trial Evidence for Rapid Approval—FASTER Approval | 3.6 | 31 | Citations (PDF) |
| 25 | An International Society for Cell and Gene Therapy Mesenchymal Stromal Cells Committee editorial on overcoming limitations in clinical trials of mesenchymal stromal cell therapy for coronavirus disease-19: time for a global registry | 0.6 | 11 | Citations (PDF) |
| 26 | Peering into the dark corners of knowledge synthesis to understand the influence of predatory journals on systematic reviews | 4.1 | 6 | Citations (PDF) |
| 27 | Engaging Patients and Caregivers in an Early Health Economic Evaluation: Discerning Treatment Value Based on Lived Experience | 3.9 | 3 | Citations (PDF) |
| 28 | Author response: A systematic assessment of preclinical multilaboratory studies and a comparison to single laboratory studies 2022, , | | 0 | Citations (PDF) |
| 29 | Author response: Epidemiological characteristics and prevalence rates of research reproducibility across disciplines: A scoping review of articles published in 2018-2019 2022, , | | 0 | Citations (PDF) |
| 30 | Systematic review and narrative review lead experts to different cancer trial predictions: a randomized trial | 4.1 | 5 | Citations (PDF) |
| 31 | MicroRNA in Human Acute Kidney Injury: A Systematic Review Protocol | 1.3 | 4 | Citations (PDF) |
| 32 | Factors contributing to fidelity in a pilot trial of individualized resistant starches for pediatric inflammatory bowel disease: a fidelity study protocol | 1.4 | 3 | Citations (PDF) |
| 33 | Navigating choice in the face of uncertainty: using a theory informed qualitative approach to identifying potential patient barriers and enablers to participating in an early phase chimeric antigen receptor T (CAR-T) cell therapy trial | 2.0 | 16 | Citations (PDF) |
| 34 | National Preclinical Sepsis Platform: developing a framework for accelerating innovation in Canadian sepsis research | 2.6 | 9 | Citations (PDF) |
| 35 | The PRISMA 2020 statement: An updated guideline for reporting systematic reviews | 8.2 | 2,700 | Citations (PDF) |
| 36 | The PRISMA 2020 statement: an updated guideline for reporting systematic reviews | 5.1 | 7,140 | Citations (PDF) |
| 37 | Mesenchymal Stromal Cell‐derived Extracellular Vesicles in Preclinical Animal Models of Tumor Growth: Systematic Review and Meta‐analysis | 3.9 | 13 | Citations (PDF) |
| 38 | The PRISMA 2020 statement: An updated guideline for reporting systematic reviews | 3.0 | 7,854 | Citations (PDF) |
| 39 | MSC-Derived Extracellular Vesicles to Heal Diabetic Wounds: a Systematic Review and Meta-Analysis of Preclinical Animal Studies | 3.9 | 51 | Citations (PDF) |
| 40 | Implementation of the Canadian Cardiovascular Society guidelines for perioperative risk assessment and management: an interrupted time series study | 1.6 | 11 | Citations (PDF) |
| 41 | Safety and efficacy of autologous whole cell vaccines in hematologic malignancies: A systematic review and meta‐analysis | 1.9 | 10 | Citations (PDF) |
| 42 | Epidemiology and reporting characteristics of preclinical systematic reviews | 5.2 | 28 | Citations (PDF) |
| 43 | The Effects of Biological Sex on Sepsis Treatments in Animal Models: A Systematic Review and a Narrative Elaboration on Sex- and Gender-Dependent Differences in Sepsis 2021, 3, e0433 | | 19 | Citations (PDF) |
| 44 | The PRISMA 2020 statement: An updated guideline for reporting systematic reviews | 4.1 | 1,960 | Citations (PDF) |
| 45 | MSC-Derived Extracellular Vesicles in Preclinical Animal Models of Bone Injury: A Systematic Review and Meta-Analysis | 3.9 | 19 | Citations (PDF) |
| 46 | Stakeholder engagement in economic evaluation: Protocol for using the nominal group technique to elicit patient, healthcare provider, and health system stakeholder input in the development of an early economic evaluation model of chimeric antigen receptor T-cell therapy | 2.0 | 5 | Citations (PDF) |
| 47 | Patient engagement in preclinical laboratory research: A scoping review | 9.0 | 60 | Citations (PDF) |
| 48 | Declaración PRISMA 2020: una guía actualizada para la publicación de revisiones sistemáticas | 0.5 | 674 | Citations (PDF) |
| 49 | Mesenchymal stromal cell extracellular vesicles as therapy for acute and chronic respiratory diseases: A meta‐analysis | 13.0 | 61 | Citations (PDF) |
| 50 | Sex- and Gender-Dependent Differences in Clinical and Preclinical Sepsis | 2.4 | 48 | Citations (PDF) |
| 51 | Neuroprotection by Remote Ischemic Conditioning in Rodent Models of Focal Ischemia: a Systematic Review and Meta-Analysis | 3.3 | 30 | Citations (PDF) |
| 52 | Surrogate Humane Endpoints in Small Animal Models of Acute Lung Injury: A Modified Delphi Consensus Study of Researchers and Laboratory Animal Veterinarians* | 0.6 | 9 | Citations (PDF) |
| 53 | 140 Past and Future Changes in Scientific Publishing | 0.6 | 0 | Citations (PDF) |
| 54 | Establishment of a consensus definition for mesenchymal stromal cells (MSC) and reporting guidelines for clinical trials of MSC therapy: a modified Delphi study protocol | 2.0 | 13 | Citations (PDF) |
| 55 | Pravila PRISMA 2020. | 0.1 | 109 | Citations (PDF) |
| 56 | Prospective Comparison of Preoperative Predictive Performance Between 3 Leading Frailty Instruments | 1.7 | 56 | Citations (PDF) |
| 57 | Mind the evidence gap: The need for trials in the prevention and management of perioperative anemia in noncardiac surgery | 0.9 | 1 | Citations (PDF) |
| 58 | A Scoping Review of Registered Clinical Trials of Cellular Therapy for COVID-19 and a Framework for Accelerated Synthesis of Trial Evidence—FAST Evidence | 1.8 | 21 | Citations (PDF) |
| 59 | An Analysis of Mesenchymal Stem Cell-Derived Extracellular Vesicles for Preclinical Use | 15.4 | 107 | Citations (PDF) |
| 60 | A Scoping Review of Registered Clinical Trials of Convalescent Plasma for COVID-19 and a Framework for Accelerated Synthesis of Trial Evidence (FAST Evidence) | 1.8 | 12 | Citations (PDF) |
| 61 | Building Canadian capacity for CAR‐T cells in relapsed/refractory acute lymphoblastic leukaemia: a retrospective cohort study | 2.5 | 1 | Citations (PDF) |
| 62 | A systematic review on the efficacy and safety of low molecular weight heparin as an anticancer therapeutic in preclinical animal models | 2.3 | 14 | Citations (PDF) |
| 63 | Defining predatory journals and responding to the threat they pose: a modified Delphi consensus process | 2.0 | 60 | Citations (PDF) |
| 64 | The effects of resistant starches on inflammatory bowel disease in preclinical and clinical settings: a systematic review and meta-analysis | 2.4 | 36 | Citations (PDF) |
| 65 | Partnering with patients to get better outcomes with chimeric antigen receptor T-cell therapy: towards engagement of patients in early phase trials | 2.9 | 15 | Citations (PDF) |
| 66 | Checklists to detect potential predatory biomedical journals: a systematic review | 7.5 | 89 | Citations (PDF) |
| 67 | The Efficacy and Safety of Low Molecular Weight Heparin Administration to Improve Survival of Cancer Patients: A Systematic Review and Meta-Analysis | 4.3 | 19 | Citations (PDF) |
| 68 | Safety and efficacy of autologous tumour cell vaccines as a cancer therapeutic to treat solid tumours and haematological malignancies: a meta-analysis protocol for two systematic reviews | 2.0 | 15 | Citations (PDF) |
| 69 | What are potential barriers and enablers to patient and physician participation in Canadian cell therapy trials for stroke? A stakeholder interview study | 2.0 | 15 | Citations (PDF) |
| 70 | Protocol for the derivation and external validation of a 30-day mortality risk prediction model for older patients having emergency general surgery (PAUSE score—Probability of mortality Associated with Urgent/emergent general Surgery in oldEr patients score) | 2.0 | 1 | Citations (PDF) |
| 71 | Stress testing journals: a quasi-experimental study of rejection rates of a previously published paper | 7.5 | 4 | Citations (PDF) |
| 72 | Preclinical Studies of MSC-Derived Extracellular Vesicles to Treat or Prevent Graft Versus Host Disease: a Systematic Review of the Literature | 3.9 | 25 | Citations (PDF) |
| 73 | The Association of Frailty With Adverse Outcomes After Multisystem Trauma: A Systematic Review and Meta-analysis | 1.7 | 31 | Citations (PDF) |
| 74 | Inflated citations and metrics of journals discontinued from Scopus for publication concerns: the GhoS(t)copus Project | 0.6 | 6 | Citations (PDF) |
| 75 | Citations and metrics of journals discontinued from Scopus for publication concerns: the GhoS(t)copus Project | 0.6 | 26 | Citations (PDF) |
| 76 | Identifying and understanding factors that affect the translation of therapies from the laboratory to patients: a study protocol | 0.6 | 3 | Citations (PDF) |
| 77 | Identifying and understanding factors that affect the translation of therapies from the laboratory to patients: a study protocol | 0.6 | 20 | Citations (PDF) |
| 78 | Postoperative shared-care for patients undergoing non-cardiac surgery: a systematic review and meta-analysis | 1.6 | 8 | Citations (PDF) |
| 79 | Personalized perioperative medicine: a scoping review of personalized assessment and communication of risk before surgery | 1.6 | 28 | Citations (PDF) |
| 80 | Assessing the Completeness of Reporting in Preclinical Oncolytic Virus Therapy Studies | 4.7 | 21 | Citations (PDF) |
| 81 | Reporting preclinical anesthesia study (REPEAT): Evaluating the quality of reporting in the preclinical anesthesiology literature | 2.5 | 15 | Citations (PDF) |
| 82 | So You Want to Give Stem Cells to Babies? Neonatologists and Parents’ Views to Optimize Clinical Trials | 2.0 | 19 | Citations (PDF) |
| 83 | Regenerative cell therapy for pulmonary arterial hypertension in animal models: a systematic review | 6.9 | 16 | Citations (PDF) |
| 84 | Knowledge and motivations of researchers publishing in presumed predatory journals: a survey | 2.0 | 105 | Citations (PDF) |
| 85 | Better With UltrasoundChest, 2019, 155, 1041-1048 | 0.5 | 18 | Citations (PDF) |
| 86 | Risks and Benefits of Chimeric Antigen Receptor T-Cell (CAR-T) Therapy in Cancer: A Systematic Review and Meta-Analysis | 1.8 | 170 | Citations (PDF) |
| 87 | Mapping the preclinical to clinical evidence and development trajectory of the oncolytic virus talimogene laherparepvec (T-VEC): a systematic review | 2.0 | 10 | Citations (PDF) |
| 88 | A Systematic Review of the Impact of Surgical Special Care Units on Patient Outcomes and Health Care Resource Utilization | 1.7 | 19 | Citations (PDF) |
| 89 | Predatory journals: no definition, no defence | 34.3 | 526 | Citations (PDF) |
| 90 | From the Lab to Patients: a Systematic Review and Meta-Analysis of Mesenchymal Stem Cell Therapy for Stroke | 3.3 | 57 | Citations (PDF) |
| 91 | Identifying stroke therapeutics from preclinical models: A protocol for a novel application of network meta-analysis | 0.6 | 13 | Citations (PDF) |
| 92 | ARE CANADIAN NEONATOLOGISTS READY FOR A STEM CELL TRIAL FOR BRONCHOPULMONARY DYSPLASIA? | 0.6 | 0 | Citations (PDF) |
| 93 | What is a predatory journal? A scoping review | 0.6 | 122 | Citations (PDF) |
| 94 | What is a predatory journal? A scoping review | 0.6 | 83 | Citations (PDF) |
| 95 | Safety and Efficacy of Adult Stem Cell Therapy for Acute Myocardial Infarction and Ischemic Heart Failure (SafeCell Heart): A Systematic Review and Meta-Analysis | 3.6 | 129 | Citations (PDF) |
| 96 | A primer on systematic reviews in toxicology | 6.2 | 76 | Citations (PDF) |
| 97 | Efficacy and safety of chimeric antigen receptor T-cell (CAR-T) therapy in patients with haematological and solid malignancies: protocol for a systematic review and meta-analysis | 2.0 | 22 | Citations (PDF) |
| 98 | Subclavian and axillary vessel anatomy: a prospective observational ultrasound study | 1.6 | 25 | Citations (PDF) |
| 99 | Stop this waste of people, animals and money | 34.3 | 228 | Citations (PDF) |
| 100 | Interventions to improve the outcomes of frail people having surgery: A systematic review | 2.5 | 95 | Citations (PDF) |
| 101 | Acquired Factor XIII Inhibitor in Hospitalized and Perioperative Patients: A Systematic Review of Case Reports and Case Series | 1.8 | 25 | Citations (PDF) |
| 102 | Can we create a Canadian Perioperative Anesthesia Clinical Trials Group? We review the first five years and glimpse into the future | 1.6 | 4 | Citations (PDF) |
| 103 | The Devil Is in the Details: Incomplete Reporting in Preclinical Animal Research | 2.5 | 113 | Citations (PDF) |
| 104 | Author response: Evaluating mesenchymal stem cell therapy for sepsis with preclinical meta-analyses prior to initiating a first-in-human trial 2016, , | | 1 | Citations (PDF) |
| 105 | Ultrasound-Guided Subclavian Vein Catheterization | 0.6 | 136 | Citations (PDF) |
| 106 | The authors reply | 0.6 | 0 | Citations (PDF) |
| 107 | Adult stem cells: potential implications for perioperative medicine | 1.6 | 0 | Citations (PDF) |
| 108 | Proteasome Inhibition Decreases Inflammation in Human Endothelial Cells Exposed to Lipopolysaccharide | 2.0 | 3 | Citations (PDF) |
| 109 | Safety of Cell Therapy with Mesenchymal Stromal Cells (SafeCell): A Systematic Review and Meta-Analysis of Clinical Trials | 2.5 | 1,016 | Citations (PDF) |
| 110 | Pulmonary Hypertension and Stem Cell Therapy 2010, , 337-365 | | 0 | Citations (PDF) |
| 111 | Title is missing! | 3.6 | 34 | Citations (PDF) |
| 112 | Evaluating mesenchymal stem cell therapy for sepsis with preclinical meta-analyses prior to initiating a first-in-human trial | 1.6 | 82 | Citations (PDF) |
| 113 | Association between neuraxial anaesthesia or general anaesthesia for lower limb revascularisation surgery in adults and clinical outcomes: population based comparative effectiveness study | 0.2 | 31 | Citations (PDF) |
| 114 | PRISMA 2020 explanation and elaboration: updated guidance and exemplars for reporting systematic reviews | 0.2 | 7,500 | Citations (PDF) |
| 115 | The PRISMA 2020 statement: an updated guideline for reporting systematic reviews | 0.2 | 64,132 | Citations (PDF) |
| 116 | Post-discharge after surgery Virtual Care with Remote Automated Monitoring-1 (PVC-RAM-1) technology versus standard care: randomised controlled trial | 0.2 | 53 | Citations (PDF) |
| 117 | A systematic assessment of preclinical multilaboratory studies and a comparison to single laboratory studies | 1.6 | 13 | Citations (PDF) |
| 118 | Epidemiological characteristics and prevalence rates of research reproducibility across disciplines: A scoping review of articles published in 2018-2019 | 1.6 | 11 | Citations (PDF) |
